» Articles » PMID: 8172922

Fragmentation into Small Vesicles of Dioleoylphosphatidylcholine Bilayers During Freezing and Thawing

Overview
Specialties Biochemistry
Biophysics
Date 1994 May 11
PMID 8172922
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Multilayered liposomes of some phosphatidylcholines progressively fragment into small vesicles when the electrolyte solution in which they are suspended is subjected to successive cycles of freezing and thawing. The fragmentation process, routinely monitored by absorbance measurements and verified by electron microscopy and dynamic light scattering, involves bilayer breakage and resealing. After 10 cycles of freezing and thawing in 0.1 M electrolyte solution, the result is a population of vesicles smaller than 200 nm diameter. Sucrose, a common cryoprotectant, completely inhibits fragmentation. Fragmentation is absolutely dependent upon the presence of an electrolyte. Those electrolytes most effective in promoting liposome fragmentation have large freezing point depressions and corresponding high solubilities at the freezing point. This, coupled with the observation that saturating concentrations of electrolyte are less effective than 0.1 M solutions indicates that an essential stage in the fragmentation process is osmotic extraction of water from the vesicles, i.e., ice formation in the external phase leads to a progressive increase in the electrolyte concentration of the residual external solution, which, in turn, dehydrates the vesicle. In addition, for maximal fragmentation, the minimum temperature must be at least as low as the solute eutectic temperature. Particular physical properties of the bilayer are also important, for dioleoyl and diphytanoyl derivatives are much more susceptible to fragmentation than are other phosphatidylcholines, and inclusion of 50 mol% cholesterol in dioleoylphosphatidylcholine completely inhibits membrane breakup. This system provides insight into mechanisms of freezing damage to membranes and may also offer a very simple and rapid assay for biological cryoprotectants.

Citing Articles

Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.

Izadiyan Z, Misran M, Kalantari K, Webster T, Kia P, Basrowi N Int J Nanomedicine. 2025; 20:1213-1262.

PMID: 39911259 PMC: 11794392. DOI: 10.2147/IJN.S488961.


Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes.

Moholkar D, Kandimalla R, Gupta R, Aqil F Cancer Lett. 2023; 565:216220.

PMID: 37209944 PMC: 10325927. DOI: 10.1016/j.canlet.2023.216220.


Lipid Membrane Binding and Cell Protection Efficacy of Poly(1,2-butylene oxide)--poly(ethylene oxide) Copolymers.

Van Zee N, Peroutka A, Crabtree A, Hillmyer M, Lodge T Biomacromolecules. 2022; 23(3):1433-1442.

PMID: 35132851 PMC: 9093290. DOI: 10.1021/acs.biomac.1c01661.


Enhanced Ribozyme-Catalyzed Recombination and Oligonucleotide Assembly in Peptide-RNA Condensates.

Le Vay K, Song E, Ghosh B, Tang T, Mutschler H Angew Chem Int Ed Engl. 2021; 60(50):26096-26104.

PMID: 34569680 PMC: 9299051. DOI: 10.1002/anie.202109267.


Occupancy distributions of membrane proteins in heterogeneous liposome populations.

Cliff L, Chadda R, Robertson J Biochim Biophys Acta Biomembr. 2019; 1862(1):183033.

PMID: 31394099 PMC: 6899186. DOI: 10.1016/j.bbamem.2019.183033.